Blog Post
What It Feels Like to Wait for a Treatment That Doesn’t Exist
One patient’s journey through rare disease diagnosis, clinical trial participation,…
Inkky: The Data Production Platform Behind Welo Data’s Frontier AI Programs
Why most data pipelines fail frontier AI programs — and…
What a Year of Agentic AI for Multilingual Content Taught Us
The operational lessons shaping Opal’s continuous evolution and the next…
How Global Brands Are Scaling Content Without Losing Brand Voice
Enterprise AI translation has entered a new phase.
Why AI Training Data Integrity Will Define Trusted AI Systems
By the time model quality degrades, the compromised data is…
Clinical Trials Are Complex. Workflows Shouldn’t Make Them Harder.
As clinical trials scale across systems, vendors, countries, and languages,…
Rethinking Patent and IP Workflows Across Jurisdictions
The hardest part of global patent filing has never been…
How AI Is Changing Multilingual Execution
From AI training data to agentic workflows, multilingual execution is…
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.
Patient recruitment has always been one of the most challenging…
How Specialization Is Reshaping Language Services
Explore how specialization is reshaping how global content gets executed…
Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global Compliance
This is the environment where life sciences translation, regulatory content…
LangMark: A New Benchmark for AI Translation Post-Editing
Discover LangMark: A new benchmark dataset designed to evaluate and…
When Product Managers Ship Code, Global Readiness Can’t Be an Afterthought
AI has collapsed execution costs, fundamentally changing where product risk…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
Regulatory Compliance in Pharmacovigilance Translations: EMA, FDA, and MHRA Requirements Explained
As the range of medicinal products grows, regulatory bodies such…
Is Your Marketing Localization Strategy Ready for What’s Next? Trends for Global Teams
Global marketing is entering a new era. Explore these trends…
EUDAMED and the New Reality for Medical Device Companies
What increased transparency means for post-market surveillance and multilingual compliance.
How Phrase and Welocalize Are Bringing Agentic AI to Enterprise Multilingual Content
An inside look at a new integration reshaping translation workflows.
The Language of Protection: Why Translation Belongs in Every Patent Strategy
Explore how legal teams are using data and technology to…
Building Trustworthy Agentic AI Starts with Diverse, High-Quality Training Data
As autonomous agents become more capable and more independent, discover…
From Pressure to Possibility: Key Insights from our MedTech Roundtable
Anja Schaefer, Welocalize Global Head of Commercial for Life Sciences,…
Navigating the Future of Linguistic Talent: Bridging AI and Human Expertise in the Language Industry
AI is reshaping localization, but human linguists remain vital. Discover…
Multilingual Accessibility in a Post-EAA World: What Global Brands Need to Know
With the European Accessibility Act (EAA) now in effect, explore…
